| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |